Boston Heart Diagnostics of Framingham, Mass., agreed on Dec. 9 to pay $26.67 million to resolve False Claims Act allegations suggesting it paid for patient referrals and improperly billed federal programs for lab testing, U.S. Attorney McGregor W. Scott announced.

Hahn is chief of radiation oncology at MD Anderson Cancer Center in Houston.

Stephen Hahn, MD, is the new commissioner of the Food and Drug Administration following approval from the U.S. Senate on Thursday, Dec. 12. 

Stephen Hahn, MD, has been confirmed as commissioner of the FDA by the Senate in a 72-18 vote.

AI is almost certain to have a monumental impact on radiology, but what, exactly, will that mean for radiologists?

The National Association of Accountable Care Organizations is launching a Direct Contracting Taskforce to offer tools and resources to assess and participate in CMS’ new direct contracting payment model, as well as provide a line of communication with CMS to advocate changes.

An FDA-approved antiarrhythmic drug known as dofetilide could be repurposed to treat pulmonary arterial hypertension, researchers have found.

Civica Rx, the not-for-profit drug company startup created by a group of hospitals and health systems to reduce drug shortages, is prepared to ship its first eight injectable medicines.

There's a 50% chance a radiologist will be tangled up in a malpractice claim by the time they turn 60. Researchers looked at the past 10 years of breast-cancer related lawsuits to better understand the medicolegal environment.

Seeking to accelerate technological capabilities, healthcare investors have been snapping up AI and machine learning companies and driving up digital health M&A in the pharmaceutical and biotechnology space as a result.